New York Times, June 2009

Cities Race to Bet on Biotech, Despite Long Odds 
New York Times, June 11, 2009

Shaila Dewan’s article on regional competition for biotech draws on the analysis we published in Signs of Life, and includes this quote:

Joseph Cortright, an economist who has studied biotechnology clusters, gave the example of a promising anti-leukemia compound developed at Oregon Health Sciences University in Portland, where Mr. Cortright is based. “The economic impact in the Portland area is zero because the rights to manufacture and market this drug were owned already by Novartis,” Mr. Cortright said